Analyze Diet
Equine veterinary journal2026; doi: 10.1002/evj.70342

Platelet-rich plasma exhibits antibacterial and anti-inflammatory effects in an in vitro donkey endometritis model.

Abstract: Infectious endometritis, mainly caused by Escherichia coli (E. coli) and Streptococcus equi subsp. zooepidemicus (SEZ), significantly impairs donkey reproductive performance. Platelet-rich plasma (PRP) shows promise as an anti-inflammatory and antibiotic alternative. Objective: To evaluate PRP's antimicrobial efficacy against key pathogens and assess its anti-inflammatory and tissue repair properties in an in vitro endometrial model. Methods: Non-randomised in vitro and explant experiments. Methods: In in vitro antibacterial assays, the inhibitory effects of PRP on the growth of E. coli and SEZ were evaluated. In an in vitro infected endometrial explant model, tissues were treated with PRP, ceftiofur (CEF), 1/2 MIC CEF, or PRP combined with 1/2 MIC CEF. Antibacterial efficacy was evaluated by bacterial load quantification, while inflammatory and healing responses were assessed by measuring the protein levels of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), anti-inflammatory cytokine (IL-10), tissue repair factor (TGF-β), matrix metallopeptidase 9 (MMP-9), and histological examination of the endometrium. Results: 50% PRP significantly inhibited E. coli and SEZ during an 8 h culture period (p < 0.05), although efficacy decreased by 24 h. In the SEZ model, PRP reduced bacterial load, IL-1β, IL-6, TNF-α, and TGF-β levels while enhancing the expression of IL-10 and MMP-9 (p < 0.05). In the E. coli model, PRP + 1/2 MIC CEF demonstrated synergistic antibacterial and optimal anti-inflammatory effects (p < 0.05). PRP also promoted epithelial and glandular repair as indicated by upregulated MMP-9 levels. Conclusions: Models may not fully replicate complex co-infections and cell interactions. Conclusions: The antibacterial efficacy of PRP depends on concentration, duration, and pathogen type, with PRP showing greater inhibitory effects against SEZ than E. coli. Application strategies should be tailored to the type of infectious endometritis to maximise the effect of PRP.
Publication Date: 2026-10-04 PubMed ID: 42830113DOI: 10.1002/evj.70342Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigated the antibacterial and anti-inflammatory effects of platelet-rich plasma (PRP) against bacterial pathogens causing infectious endometritis in donkeys, using in vitro models.
  • The research also assessed PRP’s ability to promote tissue repair in infected endometrial tissue, suggesting potential therapeutic use tailored to specific infections.

Background

  • Infectious endometritis is a uterine infection impacting donkey reproductive health, commonly caused by Escherichia coli (E. coli) and Streptococcus equi subsp. zooepidemicus (SEZ).
  • Traditional antibiotic treatments have limitations, prompting investigation into alternatives such as platelet-rich plasma (PRP), which is known for anti-inflammatory and healing properties.

Objectives

  • To evaluate the antimicrobial efficacy of PRP against E. coli and SEZ in vitro.
  • To assess PRP’s anti-inflammatory effects and ability to promote tissue repair in an in vitro donkey endometrial explant infection model.
  • To explore combination treatments using PRP and subinhibitory concentrations of the antibiotic ceftiofur (CEF) against these pathogens.

Methods

  • Antibacterial assays: In vitro experiments tested the inhibitory effects of various concentrations of PRP on bacterial growth over an 8 to 24-hour period.
  • Endometrial explant model: Donkey endometrial tissue samples were infected with E. coli or SEZ and treated with PRP alone, ceftiofur (full or half MIC), or a combination of PRP with half MIC ceftiofur.
  • Outcome measures:
    • Bacterial load quantification to measure antimicrobial efficacy.
    • Measurement of inflammatory markers — pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), anti-inflammatory cytokine (IL-10), tissue repair factor (TGF-β), and matrix metallopeptidase 9 (MMP-9).
    • Histological examination of endometrial tissue to assess epithelial and glandular repair.

Results

  • Antibacterial effects:
    • 50% PRP concentration significantly inhibited growth of both E. coli and SEZ during initial 8-hour culture (p < 0.05), but effectiveness declined by 24 hours.
    • PRP showed greater antibacterial activity against SEZ compared to E. coli.
  • Anti-inflammatory and tissue repair effects in SEZ model:
    • PRP treatment lowered levels of pro-inflammatory cytokines IL-1β, IL-6, and TNF-α (p < 0.05).
    • There was a reduction in TGF-β, a tissue repair factor, suggesting modulation of the inflammatory phase.
    • Increase in anti-inflammatory cytokine IL-10 and MMP-9, indicating enhanced healing processes and tissue remodeling.
  • Effects in E. coli model:
    • Combination of PRP with half MIC of ceftiofur (PRP + 1/2 MIC CEF) showed a synergistic effect, achieving stronger antibacterial and anti-inflammatory results than either treatment alone (p < 0.05).
    • PRP promoted repair of epithelial and glandular tissue, supported by increased MMP-9 expression.

Conclusions and Implications

  • The antibacterial efficacy of PRP depends on concentration, exposure time, and pathogen type, with better inhibitory effects against SEZ than against E. coli.
  • Combination therapy of PRP with antibiotics like ceftiofur can enhance efficacy, especially against more resistant pathogens.
  • PRP also exerts beneficial anti-inflammatory effects and promotes tissue healing, which is critical in recovery from infectious endometritis.
  • Application strategies for PRP should be adapted based on the specific infectious agent to optimize therapeutic outcomes.
  • Limitations include the in vitro model’s inability to fully replicate complex in vivo conditions such as mixed infections and cellular interactions within the uterus.
  • These findings support further development of PRP-based therapies as potential alternatives or adjuncts to antibiotics for managing infectious endometritis in donkeys.

Cite This Article

APA
Ling Y, Lan X, Duan S, Yu J, Sun J, Qu H, Lu T, Wang Z, Zhu Y, Li J. (2026). Platelet-rich plasma exhibits antibacterial and anti-inflammatory effects in an in vitro donkey endometritis model. Equine Vet J. https://doi.org/10.1002/evj.70342

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English

Researcher Affiliations

Ling, Yun
  • Equine Clinical Diagnostic Center, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Lan, Xin'er
  • Equine Clinical Diagnostic Center, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Duan, Shiyu
  • Equine Clinical Diagnostic Center, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Yu, Jie
  • National Engineering Research Center for Gelatin-Based Traditional Chinese Medicine, Shandong, China.
  • Dong-E E-Jiao Co. Ltd., Shandong, China.
Sun, Jinni
  • National Engineering Research Center for Gelatin-Based Traditional Chinese Medicine, Shandong, China.
  • Dong-E E-Jiao Co. Ltd., Shandong, China.
Qu, Honglei
  • National Engineering Research Center for Gelatin-Based Traditional Chinese Medicine, Shandong, China.
  • Dong-E E-Jiao Co. Ltd., Shandong, China.
Lu, Teng
  • National Engineering Research Center for Gelatin-Based Traditional Chinese Medicine, Shandong, China.
  • Dong-E E-Jiao Co. Ltd., Shandong, China.
Wang, Zixuan
  • Equine Clinical Diagnostic Center, College of Veterinary Medicine, China Agricultural University, Beijing, China.
  • State Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Zhu, Yiping
  • Equine Clinical Diagnostic Center, College of Veterinary Medicine, China Agricultural University, Beijing, China.
  • State Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Li, Jing
  • Equine Clinical Diagnostic Center, College of Veterinary Medicine, China Agricultural University, Beijing, China.
  • State Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, China.

Grant Funding

  • 2023YFD1302000 / National Key Research and Development Program of China

References

This article includes 56 references
  1. Gao N, Du Y, Zheng X, Shu S, Suo J, Han M. Endometritis in donkeys associated with streptococcus equi subspecies zooepidemicus infection. Equine Vet J 2021;53(S56):27.
  2. Wang Z, Zeng S, Wang Y, Wang T, Qu H, Zhu Y. Reproductive disorders in donkeys: current evidence and update. Animals 2024;14(17):2494.
  3. Morris LHA, McCue PM, Aurich C. Equine endometritis: a review of challenges and new approaches. Reproduction 2020;160(5):R95–R110.
  4. Riddle WT, LeBlanc MM, Stromberg AJ. Relationships between uterine culture, cytology and pregnancy rates in a thoroughbred practice. Theriogenology 2007;68(3):395–402.
  5. Causey RC. Making sense of equine uterine infections: the many faces of physical clearance. Vet J 2006;172(3):405–421.
  6. Gao N. Endometritis in donkeys associated with Streptococcus equi subspecies zooepidemicus infection. Pakistan Vet J 2020;40(4):537–539.
  7. Zhao Y, Zhu Y, Liu B, Mi J, Li N, Zhao W. Antimicrobial susceptibility of bacterial isolates from donkey uterine infections, 2018–2021. Vet Sci 2022;9(2):67.
  8. Davis HA, Stanton MB, Thungrat K, Boothe DM. Uterine bacterial isolates from mares and their resistance to antimicrobials: 8,296 cases (2003–2008). JAVMA 2013;242(7):977–983.
  9. Pisello L, Rampacci E, Stefanetti V, Beccati F, Hyatt DR, Coletti M. Temporal efficacy of antimicrobials against aerobic bacteria isolated from equine endometritis: an Italian retrospective analysis (2010–2017). Vet Rec 2019;185(19):598.
  10. Del Prete C, Montano C, Cocchia N, De Chiara M, Gasparrini B, Pasolini MP. Use of regenerative medicine in the treatment of endometritis in mares: a systematic review and meta‐analysis. Theriogenology 2024;227:9–20.
  11. Marini MG, Perrini C, Esposti P, Corradetti B, Bizzaro D, Riccaboni P. Effects of platelet‐rich plasma in a model of bovine endometrial inflammation in vitro. Reprod Biol Endocrinol 2016;14(1):58.
  12. Segabinazzi LG, Friso AM, Correal SB, Crespilho AM, Dell'Aqua JA, Miró J. Uterine clinical findings, fertility rate, leucocyte migration, and COX‐2 protein levels in the endometrial tissue of susceptible mares treated with platelet‐rich plasma before and after AI. Theriogenology 2017;104:120–126.
  13. Lin Y, Qi J, Sun Y. Platelet‐rich plasma as a potential new strategy in the endometrium treatment in assisted reproductive technology. Front Endocrinol 2021;12:707584.
  14. Schär MO, Diaz‐Romero J, Kohl S, Zumstein MA, Nesic D. Platelet‐rich concentrates differentially release growth factors and induce cell migration in vitro. Clin Orthop Relat Res 2015;473(5):1635–1643.
  15. Duan S, Wang Z, Jia Y, Lan X, Peng C, Deng X. Anti‐inflammatory and metabolic effects of fresh versus freeze‐dried platelet‐rich plasma on equine osteoarthritis in an ex vivo cartilage‐synovium explant co‐culture system: a pilot study. Vet Sci 2026;13(7):654.
  16. Fantini P, Jiménez R, Vilés K, Iborra A, Palhares MS, Catalán J. Simple tube centrifugation method for platelet‐rich plasma (PRP) preparation in Catalonian donkeys as a treatment of endometritis‐endometrosis.. Animals 2021;11(10):2918.
  17. Fukuda K, Kuroda T, Tamura N, Mita H, Kasashima Y. Optimal activation methods for maximizing the concentrations of platelet‐derived growth factor‐BB and transforming growth factor‐β1 in equine platelet‐rich plasma.. J Vet Med Sci 2020;82(10):1472–1479.
  18. Witte TS, Bergwerff AA, Scherpenisse P, Drillich M, Heuwieser W. Ceftiofur derivates in serum and endometrial tissue after intramuscular administration in healthy mares.. Theriogenology 2010;74(3):466–472.
  19. Nocera FP, D'Eletto E, Ambrosio M, Fiorito F, Pagnini U, De Martino L. Occurrence and antimicrobial susceptibility profiles of Streptococcus equi subsp. zooepidemicus strains isolated from mares with fertility problems.. Antibiotics (Basel, Switzerland) 2021;11(1):25.
  20. Von Dollen KA, Jones M, Beachler T, Harris TL, Papich MG, Lyle SK. Antimicrobial activity of ceftiofur and penicillin with gentamicin against Escherichia coli and Streptococcus equi subspecies zooepidemicus in an ex vivo model of equine postpartum uterine disease.. J Equine Vet Sci 2019;79:121–126.
  21. NCCLS. NCCLS methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard.. Wayne, PA: Clinical and Laboratory Standards Institute; 2019. p. 88.
  22. Monteiro De Barros MR, Davies‐Morel MCG, Mur LAJ, Creevey CJ, Alison RH, Nash DM. Characterization of an ex vivo equine endometrial tissue culture model using next‐generation RNA‐sequencing technology.. Animals (Basel) 2021;11(7):1995.
  23. Nash D, Lane E, Herath S, Martin Sheldon I. Endometrial explant culture for characterizing equine endometritis.. Am J Reprod Immunol 2008;59(2):105–117.
  24. Wu R, Yu F, Holyoak GR, Gao Y, Zhu Y, Li J. Use of the endometrial histopathology to improve diagnosis of donkeys with endometritis.. Equine Vet Educ 2024;36(1):43–50.
  25. Smith OJ, Wicaksana A, Davidson D, Spratt D, Mosahebi A. An evaluation of the bacteriostatic effect of platelet‐rich plasma.. Int Wound J 2021;18(4):448–456.
  26. Hahn O, Kieb M, Jonitz‐Heincke A, Bader R, Peters K, Tischer T. Dose‐dependent effects of platelet‐rich plasma powder on chondrocytes in vitro.. Am J Sports Med 2020;48(7):1727–1734.
  27. Eppley BL, Pietrzak WS, Blanton M. Platelet‐rich plasma: a review of biology and applications in plastic surgery.. Plast Reconstr Surg 2006;118(6):147e–159e.
  28. Yang W y, Han Y h, Cao X w, Pan J k, Zeng L f, Lin J t. Platelet‐rich plasma as a treatment for plantar fasciitis: a meta‐analysis of randomized controlled trials.. Medicine (Baltimore) 2017;96(44):e8475.
  29. Intravia J, Allen DA, Durant TJ, McCarthy MB, Russell R, Beitzel K. In vitro evaluation of the anti‐bacterial effect of two preparations of platelet rich plasma compared with cefazolin and whole blood.. Muscles Ligaments Tendons J 2014;4(1):79–84.
  30. Sethi D, Martin KE, Shrotriya S, Brown BL. Systematic literature review evaluating evidence and mechanisms of action for platelet‐rich plasma as an antibacterial agent.. J Cardiothorac Surg 2021;16(1):277–319.
  31. Aboelsaad E, Moustafa S, Amine A, Deghady A, El‐Attar L. Platelet‐rich plasma as a potential antimicrobial agent against multidrug‐resistant bacteria in diabetic foot infections.. Sci Rep 2025;15(1):15145.
  32. Oneto P, Etulain J. PRP in wound healing applications.. Platelets 2021;32(2):189–199.
  33. Burnouf T, Chou M, Wu Y, Su C, Lee L. Antimicrobial activity of platelet (PLT)‐poor plasma, PLT‐rich plasma, PLT gel, and solvent/detergent‐treated PLT lysate biomaterials against wound bacteria.. Transfusion 2013;53(1):138–146.
  34. Li G, Yin J, Ding H, Jia W, Zhang C. Efficacy of leukocyte‐ and platelet‐rich plasma gel (L‐PRP gel) in treating osteomyelitis in a rabbit model.. J Orthop Res 2013;31(6):949–956.
  35. Cl K, Jeyaraman M, Jeyaraman N, Ramasubramanian S, Khanna M, Yadav S. Antimicrobial effects of platelet‐rich plasma and platelet‐rich fibrin: a scoping review.. Cureus 2023;15(12):e51360.
  36. Yang SC, Lin CF, Alshetaili A, Aljuffali IA, Chien MY, Fang JY. Combining the dual antibacterial and regenerative activities of platelet‐rich plasma with β‐lactams to mitigate MRSA‐infected skin wounds.. Biomed Pharmacother 2023;165:115017.
  37. Reghini MFS, Ramires Neto C, Segabinazzi LG, Castro Chaves MMB, Dell'Aqua CDPF, Bussiere MCC. Inflammatory response in chronic degenerative endometritis mares treated with platelet‐rich plasma.. Theriogenology 2016;86(2):516–522.
  38. Mah TFC, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents.. Trends Microbiol 2001;9(1):34–39.
  39. Levison ME, Levison JH. Pharmacokinetics and pharmacodynamics of antibacterial agents.. Infect Dis Clin North Am 2009;23(4):791–815.
  40. Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets.. Infect Immun 2002;70(12):6524–6533.
  41. Kozhyn V, Kukhtyn M, Horiuk V, Vichko O, Kryzhanivsky Y. The activity of the disinfectant “Enzidez” against bacteria in biofilms.. Sci Mess LNU Vet Med Biotechnol 2021;23(101):67–74.
  42. Braz VS, Melchior K, Moreira CG. Escherichia coli as a multifaceted pathogenic and versatile bacterium.. Front Cell Infect Microbiol 2020;10:548492.
  43. Kaur P, Dudeja PK. Pathophysiology of enteropathogenic Escherichia coli‐induced diarrhea.. Newborn (Clarksville) 2023;2(1):102–113.
  44. El‐Nahhal IM, Salem J, Anbar R, Kodeh FS, Elmanama A. Preparation and antimicrobial activity of ZnO‐NPs coated cotton/starch and their functionalized ZnO‐Ag/cotton and Zn(II) curcumin/cotton materials.. Sci Rep 2020;10(1):5410.
  45. Lin W, Zhang J, Xu JF, Pi J. The advancing of selenium nanoparticles against infectious diseases.. Front Pharmacol 2021;12:682284.
  46. Sanman LE, Qian Y, Eisele NA, Ng TM, Van Der Linden WA, Monack DM. Disruption of glycolytic flux is a signal for inflammasome signaling and pyroptotic cell death.. Elife 2016;5:e13663.
  47. Xu G, Guo Z, Liu Y, Yang Y, Lin Y, Li C. Gasdermin D protects against Streptococcus equi subsp. zooepidemicus infection through macrophage pyroptosis.. Front Immunol 2022;13:1005925.
  48. Long N, Deng J, Qiu M, Zhang Y, Wang Y, Guo W. Inflammatory and pathological changes in Escherichia coli infected mice.. Heliyon 2022;8(12):e12533.
  49. Fang H, Gong C, Fu J, Liu X, Bi H, Cheng Y. Evaluation of 2 rat models for sepsis developed by improved cecal ligation/puncture or feces intraperitoneal‐injection.. Med Sci Monit 2020;26:e919054.
  50. Li XQ, Zhu YH, Zhang HF, Yue Y, Cai ZX, Lu QP. Risks associated with high‐dose lactobacillus rhamnosus in an Escherichia coli model of piglet diarrhoea: intestinal microbiota and immune imbalances.. PLoS One 2012;7(7):e40666.
  51. Tiba MH, McCracken BM, Dickson RP, Nemzek JA, Colmenero CI, Leander DC. A comprehensive assessment of multi‐system responses to a renal inoculation of uropathogenic E. coli in swine.. PLoS One 2020;15(12):e0243577.
  52. Zhang H, Kuchroo V. Epigenetic and transcriptional mechanisms for the regulation of IL‐10.. Semin Immunol 2019;44:101324.
  53. Zaga‐Clavellina V, Garcia‐Lopez G, Flores‐Pliego A, Merchant‐Larios H, Vadillo‐Ortega F. In vitro secretion and activity profiles of matrix metalloproteinases, MMP‐9 and MMP‐2, in human term extra‐placental membranes after exposure to Escherichia coli.. Reprod Biol Endocrinol 2011;9(1):13.
  54. Schulte W, Bernhagen J, Bucala R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets—an updated view.. Mediators Inflamm 2013;2013:1–16.
  55. Liu X, Wang Y, Wen X, Hao C, Ma J, Yan L. Platelet rich plasma alleviates endometritis induced by lipopolysaccharide in mice via inhibiting TLR4/NF‐κB signaling pathway.. Am J Reprod Immunol 2024;91(3):e13833.
  56. Farghali HA, AbdElKader NA, Fathi M, Emam IA, AbuBakr HO, Alijuaydi SH. The efficiency of intrauterine infusion of platelet‐rich plasma in the treatment of acute endometritis as assessed by endoscopic, doppler, oxidative, immunohistochemical, and gene expression alterations in jennies.. Theriogenology 2022;181:147–160.

Citations

This article has been cited 0 times.